Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma

Molecular Cancer

Volumn 14, Issue 1, 2015, Pages

  Tong, Yu Suo ^a   Wang, Xiao Wei ^b   Zhou, Xi Lei ^b   Liu, Zi Hao ^a   Yang, Tong Xin ^a   Shi, Wei Hong ^a   Xie, Hai Wei ^a   Lv, Jin ^a   Wu, Qing Quan ^b   Cao, Xiu Feng ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE AFFILIATED HUAIAN NO 1 PEOPLE S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Biomarker; Diagnosis; Esophageal cancer; Long non coding RNAs; Plasma

Indexed keywords

BETA ACTIN; LONG UNTRANSLATED RNA; LONG UNTRANSLATED RNA PLNCRNA1; LONG UNTRANSLATED RNA 91H; LONG UNTRANSLATED RNA AFAP1 AS1; LONG UNTRANSLATED RNA HNF1A AS1; LONG UNTRANSLATED RNA HOTAIR; LONG UNTRANSLATED RNA HPRT1; LONG UNTRANSLATED RNA POU3F3; LONG UNTRANSLATED RNA SPRY4 IT1; SPROUTY PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG; SERINE PROTEINASE INHIBITOR; SQUAMOUS CELL CARCINOMA-RELATED ANTIGEN; TUMOR ANTIGEN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CARCINOGENESIS; CIRCULATION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EARLY CANCER; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; EXPLORATORY RESEARCH; FEMALE; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; REPRODUCIBILITY; RNA ANALYSIS; RNA STABILITY; SENSITIVITY AND SPECIFICITY; TUMOR CELL; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CARCINOMA, SQUAMOUS CELL; CASE CONTROL STUDY; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NUDE MOUSE; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC;

ANIMALS; ANTIGENS, NEOPLASM; BIOMARKERS, TUMOR; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM STAGING; REPRODUCIBILITY OF RESULTS; RNA STABILITY; RNA, LONG NONCODING; ROC CURVE; SERPINS;

EID: 84929312910     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-14-3     Document Type: Article

References (44)

1. van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, Richel DJ, Nieuwenhuijzen GA, Hospers GA, Bonenkamp JJ, Cuesta MA, Blaisse RJ, Busch OR, ten Kate FJ, Creemers GJ, Punt CJ, Plukker JT, Verheul HM, Spillenaar Bilgen EJ, van Dekken H, van der Sangen MJ, Rozema T, Biermann K, Beukema JC, Piet AH, van Rij CM, Reinders JG, Tilanus HW, van der Gaast A, CROSS Group: Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 2012, 366:2074-2084. 10.1056/NEJMoa1112088
2. Sakai NS, Samia-Aly E, Barbera M, Fitzgerald RC: A review of the current understanding and clinical utility of miRNAs in esophageal cancer. Semin Cancer Biol 2013, 23:512-521. 10.1016/j.semcancer.2013.08.005
3. Hirajima S, Komatsu S, Ichikawa D, Takeshita H, Konishi H, Shiozaki A, Morimura R, Tsujiura M, Nagata H, Kawaguchi T, Arita T, Kubota T, Fujiwara H, Okamoto K, Otsuji E: Clinical impact of circulating miR-18a in plasma of patients with oesophageal squamous cell carcinoma. Br J Cancer 2013, 108:1822-1829. 10.1038/bjc.2013.148
4. Kosugi S, Nishimaki T, Kanda T, Nakagawa S, Ohashi M, Hatakeyama K: Clinical significance of serum carcinoembryonic antigen, carbohydrate antigen 19-9, and squamous cell carcinoma antigen levels in esophageal cancer patients. World J Surg 2004, 28:680-685.
5. Qi P, Du X: The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Mod Pathol 2012, 26:155-165.
6. Ren S, Wang F, Shen J, Sun Y, Xu W, Lu J, Wei M, Xu C, Wu C, Zhang Z, Gao X, Liu Z, Hou J, Huang J, Sun Y: Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer. Eur J Cancer 2013, 49:2949-2959. 10.1016/j.ejca.2013.04.026
7. Li X, Wu Z, Mei Q, Guo M, Fu X, Han W: Long non-coding RNA HOTAIR, a driver of malignancy, predicts negative prognosis and exhibits oncogenic activity in oesophageal squamous cell carcinoma. Br J Cancer 2013, 109:2266-2278. 10.1038/bjc.2013.548
8. Redis RS, Sieuwerts AM, Look MP, Tudoran O, Ivan C, Spizzo R, Zhang X, de Weerd V, Shimizu M, Ling H, Buiga R, Pop V, Irimie A, Fodde R, Bedrosian I, Martens JW, Foekens JA, Berindan-Neagoe I, Calin GA: CCAT2, a novel long non-coding RNA in breast cancer expression study and clinical correlations. Oncotarget 2013, 4:1748-1762.
9. Gutschner T, Hämmerle M, Eissmann M, Hsu J, Kim Y, Hung G, Revenko A, Arun G, Stentrup M, Gross M, Zörnig M, MacLeod AR, Spector DL, Diederichs S: The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res 2013, 73:1180-1189. 10.1158/0008-5472.CAN-12-2850
10. Yuan S-X, Yang F, Yang Y, Tao Q-F, Zhang J, Huang G, Yang Y, Wang R-Y, Yang S, Huo X-S, Zhang L, Wang F, Sun SH, Zhou WP: Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients' poor recurrence-free survival after hepatectomy. Hepatology 2012, 56:2231-2241. 10.1002/hep.25895
11. Liu Q, Huang J, Zhou N, Zhang Z, Zhang A, Lu Z, Wu F, Mo YY: LncRNA loc285194 is a p53-regulated tumor suppressor. Nucleic Acids Res 2013, 41:4976-4987. 10.1093/nar/gkt182
12. Tsui NB, Ng EK, Lo YM: Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clin Chem 2002, 48:1647-1653.
13. Zanutto S, Pizzamiglio S, Ghilotti M, Bertan C, Ravagnani F, Perrone F, Leo E, Pilotti S, Verderio P, Gariboldi M, Pierotti MA: Circulating miR-378 in plasma: a reliable, haemolysis-independent biomarker for colorectal cancer. Br J Cancer 2014, 110:1001-1007. 10.1038/bjc.2013.819
14. Zhang J, Zhao H, Gao Y, Zhang W: Secretory miRNAs as novel cancer biomarkers. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2012, 1826:32-43. 10.1016/j.bbcan.2012.03.001
15. Shao Y, Ye M, Jiang X, Sun W, Ding X, Liu Z, Ye G, Zhang X, Xiao B, Guo J: Gastric juice long noncoding RNA used as a tumor marker for screening gastric cancer. Cancer 2014.
16. Chen F-J, Sun M, Li S-Q, Wu Q-Q, Ji L, Liu Z-L, Zhou G-Z, Cao G, Jin L, Xie H-W, Wang CM, Lv J, De W, Wu M, Cao XF: Upregulation of the long non-coding rna hotair promotes esophageal squamous cell carcinoma metastasis and poor prognosis. Mol Carcinog 2013, 52:908-915. 10.1002/mc.21944
17. Wu W, Bhagat TD, Yang X, Song JH, Cheng Y, Agarwal R, Abraham JM, Ibrahim S, Bartenstein M, Hussain Z, Suzuki M, Yu Y, Chen W, Eng C, Greally J, Verma A, Meltzer SJ: Hypomethylation of noncoding DNA regions and overexpression of the long noncoding RNA, AFAP1-AS1, in Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology 2013, 144:956-966. e954 10.1053/j.gastro.2013.01.019
18. Li W, Zheng J, Deng J, You Y, Wu H, Li N, Lu J, Zhou Y: Increased levels of the long intergenic non-protein coding RNA POU3F3 promote DNA methylation in esophageal squamous cell carcinoma cells. Gastroenterology 2014, 146:1714-1726. e1715 10.1053/j.gastro.2014.03.002
19. Yang X, Song JH, Cheng Y, Wu W, Bhagat T, Yu Y, Abraham JM, Ibrahim S, Ravich W, Roland BC, Khashab M, Singh VK, Shin EJ, Yang X, Verma AK, Meltzer SJ, Mori Y: Long non-coding RNA HNF1A-AS1 regulates proliferation and migration in oesophageal adenocarcinoma cells. Gut 2014, 63:881-890. 10.1136/gutjnl-2013-305266
20. Gao T, He B, Pan Y, Xu Y, Li R, Deng Q, Sun H, Wang S: Long non-coding RNA 91H contributes to the occurrence and progression of esophageal squamous cell carcinoma by inhibiting IGF2 expression. Mol Carcinog 2014.
21. Wang CM, Wu QQ, Li SQ, Chen FJ, Tuo L, Xie HW, Tong YS, Ji L, Zhou GZ, Cao G, Wu M, Lv J, Shi WH, Cao XF: Upregulation of the long non-coding RNA PlncRNA-1 promotes esophageal squamous carcinoma cell proliferation and correlates with advanced clinical stage. Dig Dis Sci 2014,59(8):591-597.
22. Xie HW, Wu QQ, Zhu B, Chen FJ, Ji L, Li SQ, Wang CM, Tong YS, Tuo L, Wu M, Liu ZH, Lv J, Shi WH, Cao XF: Long noncoding RNA SPRY4-IT1 is upregulated in esophageal squamous cell carcinoma and associated with poor prognosis. Tumour Biol 2014,35(8):7743-7754. 10.1007/s13277-014-2013-y
23. Li J, Chen Z, Tian L, Zhou C, He MY, Gao Y, Wang S, Zhou F, Shi S, Feng X, Sun N, Liu Z, Skogerboe G, Dong J, Yao R, Zhao Y, Sun J, Zhang B, Yu Y, Shi X, Luo M, Shao K, Li N, Qiu B, Tan F, Chen R, He J: LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma. Gut 2014,63(11):1700-1710. 10.1136/gutjnl-2013-305806
24. Andersen CL, Jensen JL, Ørntoft TF: Normalization of real-time quantitative reverse transcription-PCR data a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 2004, 64:5245-5250. 10.1158/0008-5472.CAN-04-0496
25. Pritchard CC, Kroh E, Wood B, Arroyo JD, Dougherty KJ, Miyaji MM, Tait JF, Tewari M: Blood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker Studies. Cancer Prevent Res 2011, 5:492-497.
26. Schwarzenbach H, Hoon DS, Pantel K: Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 2011, 11:426-437. 10.1038/nrc3066
27. Lukaszewicz-Zajac M, Mroczko B, Kozlowski M, Niklinski J, Laudanski J, Szmitkowski M: Higher importance of interleukin 6 than classic tumor markers (carcinoembryonic antigen and squamous cell cancer antigen) in the diagnosis of esophageal cancer patients. Dis Esophagus 2012, 25:242-249. 10.1111/j.1442-2050.2011.01242.x
28. Zheng X, Xing S, Liu XM, Liu W, Liu D, Chi PD, Chen H, Dai SQ, Zhong Q, Zeng MS, Liu WL: Establishment of using serum YKL-40 and SCCA in combination for the diagnosis of patients with esophageal squamous cell carcinoma. BMC Cancer 2014, 14:490-500. 10.1186/1471-2407-14-490
29. Zhou JH, Zhang B, Kernstine KH, Zhong L: Autoantibodies against MMP-7 as a novel diagnostic biomarker in esophageal squamous cell carcinoma. World J Gastroenterol 2011, 17:1373-1378. 10.3748/wjg.v17.i10.1373
30. Takeshita N, Hoshino I, Mori M, Akutsu Y, Hanari N, Yoneyama Y, Ikeda N, Isozaki Y, Maruyama T, Akanuma N, Komatsu A, Jitsukawa M, Matsubara H: Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma. Br J Cancer 2013, 108:644-652. 10.1038/bjc.2013.8
31. Yamamoto K, Oka M, Hayashi H, Tangoku A, Gondo T, Suzuki T: CYFRA 21-1 is a useful marker for esophageal squamous cell carcinoma. Cancer 1997, 79:1647-1655. Publisher Full Text 10.1002/(SICI)1097-0142(19970501)79:9<1647::AID-CNCR3>3.0.CO;2-9
32. Łukaszewicz-Zajac M, Mroczko B, Kozłowski M, Nikliński J, Laudański J, Szmitkowski M: Elevated levels of serum metalloproteinase 9 in patients with esophageal squamous cell carcinoma. Pol Arch Med Wewn 2009, 119:558-563.
33. Lardizabal MN, Nocito AL, Daniele SM, Ornella LA, Palatnik JF, Veggi LM: Reference genes for real-time PCR quantification of microRNAs and messenger RNAs in rat models of hepatotoxicity. PLoS One 2012, 7:e36323. 10.1371/journal.pone.0036323
34. Sauer E, Babion I, Madea B, Courts C: An evidence based strategy for normalization of quantitative PCR data from miRNA expression analysis in forensic organ tissue identification. Forensic Sci Int Genet 2014, 13:217-223.
35. Jacob F, Guertler R, Naim S, Nixdorf S, Fedier A, Hacker NF, Heinzelmann-Schwarz V: Careful selection of reference genes is required for reliable performance of RT-qPCR in human normal and cancer cell lines. PLoS One 2013, 8:e59180. 10.1371/journal.pone.0059180
36. Ng EK, Tsui NB, Lam NY, Chiu RW, Yu SC, Wong SC, Lo ES, Rainer TH, Johnson PJ, Lo YM: Presence of Filterable and Nonfilterable mRNA in the Plasma of Cancer Patients and Healthy Individuals. Clin Chem 2002, 48:1212-1217.
37. Wittmann J, Jäck H-M: Serum microRNAs as powerful cancer biomarkers. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2010, 1806:200-207. 10.1016/j.bbcan.2010.07.002
38. Redova M, Sana J, Slaby O: Circulating miRNAs as new blood-based biomarkers for solid cancers. Future Oncol 2013, 9:387-402. 10.2217/fon.12.192
39. Reis EM, Verjovski-Almeida S: Perspectives of Long Non-Coding RNAs in Cancer Diagnostics. Frontiers Genet 2012, 3:1-8.
40. Chen G, Wang J, Cui Q: Could circulating miRNAs contribute to cancer therapy. Trends Mol Med 2013, 19:71-73. 10.1016/j.molmed.2012.10.006
41. Liu J, Gao J, Du Y, Li Z, Ren Y, Gu J, Wang X, Gong Y, Wang W, Kong X: Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer. Int J Cancer 2012, 131:683-691. 10.1002/ijc.26422
42. Kumarswamy R, Bauters C, Volkmann I, Maury F, Fetisch J, Holzmann A, Lemesle G, de Groote P, Pinet F, Thum T: Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure. Circ Res 2014, 114:1569-1575. 10.1161/CIRCRESAHA.114.303915
43. Sobin LH, Gospodarowicz MK, Wittekind C: TNM classification of malignant tumours, 7th edition. 2010.
44. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT: The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009, 55:611-622. 10.1373/clinchem.2008.112797